Prognostic Cancer Biomarkers
The genetic diversity associated with cancer cells are shocking huge; and identifying a suitable prognostic marker is a real challenge. Prognostic cancer markers aims to evaluate objectively a patient’s overall outcome, response to treatment and chances of cancer recurrence. Prognostic markers can also help to select patients for a particular treatments and help predict the beneficial effect of the therapy. DNA, RNA, epigenetic patterns, signaling pathways, proteins, and metabolic biomolecules have been used as prognostic cancer markers. (Mehta et al., 2010)
Given below are few prognostic biomarkers commonly used in cancer medicine:
1. Beta tubulin: Beta tubulin regulates microtubule assembly in the cell. Class III tubulin are expressed by tumor of both neuronal ...